Can Hydroxyzine Show Up on a Drug Test?

Hydroxyzine itself is not a controlled substance and is not one of the drugs that standard workplace or clinical drug panels are designed to detect. However, it can trigger a false-positive result on certain immunoassay-based screens, most commonly registering as a tricyclic antidepressant (TCA). This means that while a drug test is not looking for hydroxyzine, the drug’s chemical structure can confuse the test into flagging something it is not. The false positive is well documented in the pharmacology literature, and understanding the specifics can save you a lot of unnecessary worry.

How a Standard Drug Screen Works and Where Hydroxyzine Fits

Most routine drug tests, whether for employment, probation, or clinical purposes, use immunoassay technology. These tests rely on antibodies designed to bind to a target drug or its metabolites. The problem is that antibodies are not perfectly selective. When a substance in your sample has a molecular shape similar enough to the target drug, it can bind to the antibody and register as a positive even though the actual target drug is nowhere in your system. This is a false positive, and it happens with a surprising number of over-the-counter and prescription medications.

Hydroxyzine is a first-generation antihistamine prescribed for anxiety, itching, and sedation. It is not a benzodiazepine, opioid, amphetamine, or any other class of drug that a standard panel screens for. Yet it has been flagged repeatedly in clinical literature as a source of false-positive results. A literature review of false-positive drug tests among patients on psychiatric medications identified hydroxyzine alongside drugs like quetiapine, bupropion, and sertraline as medications associated with erroneous positive results.¹

The Tricyclic Antidepressant False Positive

The specific cross-reactivity that hydroxyzine is most associated with is a false-positive reading for tricyclic antidepressants. TCAs are an older class of medications like amitriptyline and nortriptyline, and some immunoassay panels include a TCA screen. When hydroxyzine or its active metabolite cetirizine is present in a blood or urine sample, certain immunoassay platforms will register what appears to be significant TCA concentrations even though no tricyclic antidepressant was taken.

A study examining this phenomenon directly found that when drug-free serum samples were spiked with hydroxyzine or cetirizine, the fluorescence polarization immunoassay (FPIA) method reported apparent TCA concentrations. The same interference occurred when serum from patients actually receiving TCAs was supplemented with hydroxyzine or cetirizine, artificially inflating the measured TCA level.² This is a particular concern in emergency medicine, where TCA overdose screening is done rapidly using immunoassay methods, and a false alarm could lead to unnecessary treatment.

The interference has also been documented with another immunoassay platform, the particle-enhanced turbidimetric inhibition immunoassay, which is used in some clinical laboratories for the same TCA screening purpose.³ So this is not a quirk of one particular testing machine; it affects multiple commonly used immunoassay formats.

A resource from the University of Illinois at Chicago’s Drug Information Group lists hydroxyzine among several medications that have produced false-positive results in serum drug screens, alongside diphenhydramine (Benadryl), cyproheptadine, and carbamazepine.⁴ The structural similarity among these first-generation antihistamines and the tricyclic antidepressant backbone is what makes the antibody-based tests trip up.

Why Cetirizine Matters Too

A detail that catches people off guard is that hydroxyzine is rapidly converted in the body to cetirizine, which you may recognize as the active ingredient in Zyrtec. This conversion is extensive. In pharmacokinetic studies, the amount of cetirizine circulating in the bloodstream after a dose of hydroxyzine vastly exceeds the amount of hydroxyzine itself, with cetirizine levels reaching roughly eight to ten times those of the parent drug.⁵

This is relevant to drug testing because cetirizine itself also causes false-positive TCA readings on immunoassay screens.² So even after hydroxyzine itself has largely cleared from your system, its dominant metabolite can continue to create interference with immunoassay-based testing. This also raises the question of whether people taking over-the-counter cetirizine (Zyrtec) might face the same issue, and the answer is yes, at least in principle, though the doses involved and the resulting serum concentrations would need to be high enough to cross-react.

How Long Hydroxyzine Stays in Your System

How long the drug and its metabolites remain detectable depends on several factors, but the elimination half-life gives you a reasonable starting point. In adults, hydroxyzine’s elimination half-life is roughly 20 hours.⁶ That means it takes about 20 hours for your body to cut the amount of hydroxyzine in your blood in half. As a general rule, a drug is considered functionally eliminated after four to five half-lives, which puts the rough clearance window for hydroxyzine at around four to five days in a typical healthy adult.

In children, the half-life is shorter. One study in pediatric patients found a mean half-life of about 7 hours, and the half-life increased with age within the pediatric population studied.⁷ The practical takeaway is that children clear the drug faster than adults.

But the drug itself is only part of the equation. Because cetirizine is the primary metabolite and it also causes immunoassay interference, you need to account for cetirizine’s clearance as well. Cetirizine has its own elimination half-life, typically around 7 to 11 hours in healthy adults. Combined with the time it takes to form from hydroxyzine, the total window during which some cross-reactive substance is circulating can extend beyond what you would expect from hydroxyzine’s half-life alone.

People Who Clear Hydroxyzine More Slowly

Liver function has a major impact on how quickly hydroxyzine leaves your system. Hydroxyzine is metabolized in the liver, and people with impaired liver function can clear it much more slowly. A study of patients with primary biliary cirrhosis found that the mean elimination half-life of hydroxyzine was about 37 hours, nearly double the typical adult value. The metabolite cetirizine also lingered longer, with a half-life of about 25 hours in the same patients.⁸

Older adults also tend to have slower hepatic metabolism, which is consistent with the finding that hydroxyzine’s half-life increases with age. If you are elderly or have any degree of liver disease, the drug and its metabolites will be present in your system for longer, extending both the therapeutic effects and the window during which immunoassay interference is possible.

What Happens After a Positive Screening Result

If you take hydroxyzine and a drug screen comes back positive for TCAs, the next step in any properly run testing program is confirmatory testing. The initial immunoassay screen is designed to be sensitive, catching as many positives as possible at the cost of some false alarms. The confirmatory test uses a completely different technology, usually liquid chromatography coupled with mass spectrometry (LC-MS/MS), which identifies drugs by their exact molecular structure rather than by antibody binding.

LC-MS/MS methods can readily distinguish hydroxyzine from tricyclic antidepressants because the molecules have different masses and fragmentation patterns. In evaluations of these confirmatory methods, hydroxyzine was correctly identified in patient samples with high reliability.⁹ In other words, a false-positive immunoassay result for TCAs caused by hydroxyzine will not survive confirmatory testing. The confirmatory test will correctly show that no TCA is present and will identify hydroxyzine if it is specifically looked for.

More advanced LC-MS/MS methods have been developed for forensic and clinical use that can simultaneously quantify hydroxyzine and cetirizine in blood, urine, and other biological samples with very high sensitivity and accuracy.¹⁰ Validated methods can detect hydroxyzine at concentrations as low as 0.5 nanograms per milliliter of blood.¹¹ These methods exist for situations where knowing whether someone has taken hydroxyzine specifically matters, such as in forensic toxicology or clinical overdose cases.

When Hydroxyzine Itself Is What They Are Looking For

There is a distinct scenario from the false-positive question: situations where a lab is specifically testing for hydroxyzine. This comes up primarily in forensic toxicology, such as death investigations, impaired driving cases, or overdose evaluations. Hydroxyzine has sedative properties and can impair coordination and reaction time, making it relevant in accident investigations.

In postmortem toxicology, standard screening protocols typically include an alkaline drug screen by gas chromatography-mass spectrometry (GC-MS), and hydroxyzine can be detected through this approach. When it appears, it is then confirmed and quantified using a targeted procedure.¹² Forensic laboratories have increasingly adopted LC-MS/MS methods that can detect and quantify hydroxyzine alongside its cetirizine metabolite in blood, urine, and even less common sample types like vitreous humor and bile.¹⁰

Standard workplace drug panels (the typical 5-panel or 10-panel tests used for employment) do not include hydroxyzine as a target. These panels screen for classes like amphetamines, cannabinoids, cocaine, opiates, and PCP, sometimes with expanded panels including benzodiazepines, barbiturates, or methadone. Hydroxyzine is not in any of these categories. The only way it shows up in a routine employment test is through the false-positive mechanism described above, and even then, only if the panel includes a TCA screen, which many standard workplace panels do not.

What You Should Do Before a Drug Test

If you are prescribed hydroxyzine and you know a drug test is coming, the most straightforward step is to disclose the medication to the testing facility or the medical review officer (MRO) beforehand. In workplace testing programs regulated by federal agencies, results that come back positive on the initial immunoassay automatically go to confirmatory testing, and a medical review officer reviews the results with the donor before a final determination. If you have a legitimate prescription, that typically resolves the issue.

You should not stop taking a prescribed medication solely to avoid a drug test without talking to your prescriber first. Hydroxyzine is sometimes used for anxiety, and abrupt discontinuation could lead to a rebound in symptoms. The better approach is transparency: bring documentation of your prescription, and let the process work as designed. The confirmatory test will distinguish hydroxyzine from any illicit substance.

One practical concern is timing. If you have flexibility over when you take the test and you have recently stopped hydroxyzine (with your doctor’s guidance), waiting several days will reduce or eliminate circulating levels of the drug and its metabolites. Given the roughly 20-hour half-life in healthy adults, a wait of four to five days after your last dose would bring levels down to nearly undetectable in most people. People with liver impairment would need longer.

Diphenhydramine and Other Antihistamines That Cause Similar Problems

Hydroxyzine is not the only antihistamine with this issue. Diphenhydramine (Benadryl) is another first-generation antihistamine that has been reported to cause false-positive results on TCA immunoassay screens, for essentially the same structural reasons.⁴ The first-generation antihistamines share a molecular architecture with tricyclic antidepressants: both feature a three-ring core structure that the immunoassay antibodies can mistake for one another.

Second-generation antihistamines like loratadine (Claritin) and fexofenadine (Allegra) have substantially different chemical structures and are not typically associated with false-positive drug test results. Cetirizine (Zyrtec) is the exception among second-generation antihistamines because, as noted earlier, it shares a structural relationship with hydroxyzine and has documented immunoassay cross-reactivity.² If you are trying to avoid any possibility of test interference and have a choice of antihistamines, loratadine or fexofenadine would be the safer options from a drug-testing standpoint.

Why This Keeps Happening Despite Being Well Known

The false-positive problem with hydroxyzine and other structurally similar medications has been documented for decades, and yet immunoassay-based screening continues to be the first-line testing method in most settings. The reason is practical: immunoassays are cheap, fast, and can process many samples at once. They serve as a triage tool, and the expectation built into any good testing program is that a positive screening result will always be confirmed by a more specific method before any consequences follow.

The trouble arises when testing programs cut corners, when results are acted on before confirmatory testing is complete, or when the person being tested does not know their rights. In clinical settings, a false-positive TCA result in an emergency department could theoretically influence treatment decisions if the clinician does not consider hydroxyzine as an interfering substance. Emergency physicians are generally trained to interpret immunoassay results cautiously, but the potential for confusion remains real when patients cannot communicate their medication history.

In forensic and postmortem toxicology, the analytical methods are more comprehensive by design. Labs in these settings routinely use GC-MS or LC-MS/MS from the outset, and hydroxyzine is part of their screening libraries. Forensic analysts are less likely to be fooled by immunoassay cross-reactivity because they often skip immunoassay entirely for non-workplace casework.¹²

Hair and Oral Fluid Testing

Most of the drug-testing literature on hydroxyzine focuses on blood and urine, which are the standard matrices for both clinical and workplace drug testing. However, drug testing technology has expanded to include hair and oral fluid (saliva) for certain applications. Hair testing is used primarily for longer detection windows, sometimes going back months, while oral fluid testing is gaining popularity for its convenience and resistance to adulteration.

Analytical methods have been developed and validated for detecting antihistamines including hydroxyzine in various biological matrices beyond blood and urine. Forensic laboratories now have the capability to identify hydroxyzine in less conventional samples such as vitreous humor, bile, and stomach contents.¹⁰ These specialized methods are not used in routine employment screening but illustrate that if there is a reason to look for hydroxyzine specifically, modern analytical chemistry can find it in almost any sample type. For the average person facing a standard workplace or probation drug test, blood and urine remain the relevant matrices, and the false-positive concern with immunoassays remains the primary practical issue.